Clinical Trial Update: Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the effectiveness of Highly Active Antiretroviral Therapy (HAART) in HIV-infected patients with tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Tuberculosis | Phase 1 | Status: COMPLETED